Allergan is still on the acquisition trail following its failed merger with Pfizer, spending $85 million to acquire privately-held Topokine Therapeutics and its late-stage product for under-eye bags.

In many ways, Allergan confirms that ODP typically applies to later-filed and later-issued patent applications, and not the other way around. A careful review of current practices should be ...

Allergan hasn’t pressed pause on business development in the build-up to its $63 billion buyout by AbbVie, and has just agreed a deal with Exicure focusing on hair loss disorders. The alliance ...

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and ...

Paine, Lynn S., Suraj Srinivasan, John C. Coates, and David Lane. "The Allergan Board Under Fire (A)." Harvard Business School Case 316-010, January 2016. (Revised January 2019.) ...

It was then that Actavis, a drug company that specializes in generic drugs and over-the-counter products, scooped up Allergan for a neat $66 billion. Here's a photo of Actavis CEO Brenton Saunders ...

Chrisman is a certified national trainer for Allergan, and is a member of the Medical Advisory ... For example, your injector might recommend Juvéderm Voluma XC for your cheeks, but Volbella XC for ...

IRVINE, Calif., Sept. 4, 2024 /PRNewswire/ -- University Lab Partners (ULP) is proud to announce NovoThelium as the winner of the 2nd annual Golden Ticket Pitch Competition for aesthetic startups ...

Now, Hill’s recent appointment as a trainer for the Allergan Medical Institute (AMI), where he joins his wife, Brittony Croasdell, has become a significant milestone. Hill and Croasdell are the ...

PHILADELPHIA, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today ...

Allergan, Janssen, and Eden Biodesigns (collectively, Allergan) asserted patent infringement against Sun Pharmaceuticals Industries (Sun) after Sun filed an abbreviated new drug application (ANDA ...